Oculopharyngeal Muscular Dystrophy (OPMD)
Oncology
Prevalence
200.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Oculopharyngeal Muscular Dystrophy (OPMD)?
There are 1 clinical trial targeting Oculopharyngeal Muscular Dystrophy (OPMD) tracked by BioSniper.
What is the prevalence of Oculopharyngeal Muscular Dystrophy (OPMD)?
The estimated prevalence of Oculopharyngeal Muscular Dystrophy (OPMD) is approximately 200.0 per 100,000 population.
Deep-dive into Oculopharyngeal Muscular Dystrophy (OPMD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis